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Abstract. Tau-mediated neurodegeneration is a central event in Alzheimer’s disease (AD) and other tauopathies. Consistent
with suggestions that lifetime stress may be a clinically-relevant precipitant of AD pathology, we previously showed that stress
triggers Tau hyperphosphorylation and accumulation; however, little is known about the etiopathogenic interaction of chronic
stress with other AD risk factors, such as sex and aging. This study focused on how these various factors converge on the cellular
mechanisms underlying Tau aggregation in the hippocampus of chronically stressed male and female (middle-aged and old) mice
expressing the most commonly found disease-associated Tau mutation in humans, P301L-Tau. We report that environmental
stress triggers memory impairments in female, but not male, P301L-Tau transgenic mice. Furthermore, stress elevates levels of
caspase-3-truncated Tau and insoluble Tau aggregates exclusively in the female hippocampus while it also alters the expression of
the molecular chaperones Hsp90, Hsp70, and Hsp105, thus favoring accumulation of Tau aggregates. Our findings provide new
insights into the molecular mechanisms through which clinically-relevant precipitating factors contribute to the pathophysiology
of AD. Our data point to the exquisite sensitivity of the female hippocampus to stress-triggered Tau pathology.
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INTRODUCTION
Tau aggregation is a common feature in Alzheimer’s
disease (AD), frontotemporal dementia, and other
tauopathies. The identification of Tau mutations has
helped establish that Tau dysfunction is central to the
neurodegenerative processes leading to dementia [1].
The most frequent human Tau mutation, P301L [2],
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results in the production of an aggregation-prone form
of the protein. Expression of pathogenic P301L-Tau
in mice results in the formation of Tau aggregates
and neurofibrillary tangles, similar to those observed
in AD brains; P301L-Tau was previously demon-
strated to promote the assembly and accumulation
of conformationally-abnormal and insoluble Tau that
triggers neuronal degeneration and loss [3, 4].
Tauopathies are complex disorders with multiple
precipitating factors. For example, age, sex, and stress-
ful life events are known etiopathogenic factors in AD
[5, 6]. While advanced age is the primary risk factor
for developing AD, potential combinatorial effects are
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likely, as illustrated by findings that: (i) the aged brain
is more vulnerable to chronic stress [7], (ii) females
are more vulnerable to stress-related disorders [8–10],
and (iii) women are more prone to develop AD [11].
Notably, elevated levels of glucocorticoid secretion,
such as those observed after stress, are associated with
hippocampal degeneration and cognitive deficits in
AD patients [12–14]; moreover, stress triggers AD-
like pathology, including Tau hyperphosphorylation
in rodents [15–17]. However, the interplay between
these diverse risk factors in the establishment of Tau
pathology is poorly understood.
In this study, middle-aged and old male and female
transgenic P301L-Tau mice [3] were used to explore
the mechanisms through which stress contributes to
Tau aggregation. Analysis focused on the hippocam-
pus, one of the first brain areas to display Tau pathology
in the course of AD as well after exposure of exper-
imental animals to stress [16, 17]. A key finding of
this work is that chronic stress triggers a number of
mechanisms, including caspase 3-driven truncation of
au and abnormal Tau conformation that leads to Tau
aggregation in female, but not male, P301L-Tau mice.
Tau aggregation in female mice was accompanied by
altered expression of molecular chaperones known to
regulate the proper degradation and aggregation of
Tau [18, 19], activation of apoptotic molecules, and
impaired memory. Together, these results add new per-
spectives to our understanding of how stress and sex




Middle-aged (12–14 months) and old (22–24
months) male and female P301L-Tau transgenic (Tg)
mice and their wildtype littermates were used in this
study. The expression of mutant human Tau is driven by
CaMKII promoter avoiding any motor deficits [20, 21].
The previously-characterized transgenic line exhibits
Tau aggregates in hippocampal neurons [3, 21, 22].
All animal experiments were performed according to
Japanese Law, were approved by the Animal Care and
Use Committee of RIKEN institute (Saitama, Japan),
and conformed with US National Institutes of Health
Guidelines on animal welfare and experimentation.
Animals were subjected to prolonged stress over a
period of 28 days [17]. Briefly, single stressors (over-
crowding; restraint; placement on a rocking platform;
i.p. injection of 0.9% saline 1 ml/100 g) were applied
on a daily basis and in random order to prevent habitua-
tion. Efficacy of this protocol was verified by reduction
of body weight (p < 0.05), increases in daytime serum
corticosterone (CORT) levels (p < 0.05), and increases
in anxiety levels measured by elevated plus maze test
(reduction in entries and time in open arms, p < 0.05)
(see Supplementary Table 1).
Behavioral testing
Spatial reference memory was assessed in the Mor-
ris water maze at the end of the 28-day stress paradigm.
As previously described [3], the maze consisted of a
cylinder (1 m diameter) filled with water (24◦C) made
opaque with a white bio-safe dye. The cylinder con-
tained a slightly submerged transparent escape plat-
form (not visible because of the opaque water) and was
placed in a room with landmark (reference) objects.
Learning trials commenced by gently placing mice on
the water surface close to the cylinder wall. Animals
were tested over 9 consecutive days (3 trials/day; 60-s
trial period). On the tenth day, the mouse had to search
(60 s) for the escape platform that was absent during
this “probe” test. Swim paths during these tests were
monitored and recorded by a CCD camera, using Image
J software (http://rsb.info.nih.gov/nih-image/). Data
were subsequently analyzed using customized soft-
ware based on Matlab (version 7.2, Mathworks Co Ltd,
CA), with an image analysis tool box (Mathworks).
Specifically, swim speed, distance from platform, and
latency to reach the platform were computed. Learn-
ing was assessed by measuring the distance between
the mouse and the platform at 0.5 s intervals until the
mouse reached the platform or the session timed out.
Next, we calculated the total distance traveled by the
mouse by integrating the distance between the mouse
and the platform, with the “integrated distance” value
providing an “error score” as previously described
[3, 21].
Western blot and immunohistological analysis
One day after the last behavioral test, half of the ani-
mals were killed by decapitation and their brains were
rapidly excised; the hippocampi were dissected, snap-
frozen and stored at –80◦C until western blot analysis.
The rest of the animals were deeply anesthetized
with pentobarbital (50 mg/kg) and transcardially per-
fused with 10% PFA. Brains were postfixed for 16 h
before embedding in paraffin, sectioning (4m) in
the coronal plane. Western blot analysis was carried
out on sarkosyl-insoluble and sarkosyl-soluble tissue
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fractions, as previously described [3, 21]. Briefly,
frozen hippocampi were homogenized in Tris-buffered
saline (TBS; 10 mM Tris, 150 mM NaCl) includ-
ing protease inhibitors (1g/ml antipine, 5g/ml
pepstatin, 5g/ml leupeptin, 2g/ml aprotinin,
and 0.5M 4-(2-aminoethyl)benzenesulfonylfluoride
hydrochloride) and phosphataseinhibitors (1 mM NaF,
0.4 mM Na3VO4, and 0.5 mM okadaic acid). After
centrifugation at 100,000 g, the supernatant (solu-
ble fraction) was collected. Sarkosyl-insoluble, paired
helical filament-enriched fractions were prepared from
the TBS-insoluble pellets after re-homogenization in
salt/sucrose buffer (0.8 M NaCl, 10 mM Tris/HCl,
pH 7.4, 10% sucrose and protease and phosphatase
inhibitors; see [5]), incubation with 10% sarkosyl
(37◦C, 1 h) and centrifugation (150,000 g). After
SDS–PAGE electrophoresis, protein extracts were
semi-dry transferred onto to nitrocellulose membranes
which were subsequently incubated with the antisera
listed in Supplementary Table 2. Signals were revealed
by enhanced chemiluminescence (ECL, GE Health-
care) and evaluated using a LAS-3000 Bio-Imaging
Analyzer System (Fujifilm). For immunohistochem-
istry, deparaffinized sections were exposed to antigen
retrieval (citrate buffer) and 0.3% Triton-X before
incubation with antiserum against MC1 (1 : 100) and
appropriate secondary antibodies followed by DAB as
previously described by our team [17]. Images were
obtained on an Olympus confocal microscope. In addi-
tion, neuronal (CA3) densities were stereologically
estimated by counting neurons in cresyl violet-stained
serial coronal brain sections, using Neurolucida soft-
ware (MBF Bioscience, Williston, VT) as previously
described by us [23]. Furthermore, apoptotic cell death
was monitored using “in situ cell death” TUNEL kit
(Roche) on brain sections following manufacturer’s
instructions.
Statistical analysis
Numerical data are expressed as group
means ± SEM. Descriptive statistics, mixed-design
factorial and multifactorial analyses of variance
(ANOVAs) were used for evaluation of main and/or
interaction effects of the factors of interest. When
significant interactions were detected, significance of
simple effects was tested by pairwise comparisons of
dependent and independent variables, using paired
or unpaired t-tests, respectively. The nominal level
of significance was set at = 0.05 and Bonferroni’s
procedure was applied in all posteriori tests to keep
the type I error ≤0.05.
RESULTS
Sex-speciﬁc susceptibility of P301L-Tau Tg mice
to the memory-impairing effects of stress
Clinical evidence indicates that, besides aging,
stress and sex influence the emergence of AD
pathology, and that these potential risk factors may
act in a combinatorial fashion [11, 13]. Our ini-
tial analysis of interactions between these factors
involved examination of the learning curves in
a hippocampus-dependent spatial learning-memory
test (Fig. 1A–D). Mixed-designed factorial ANOVA
revealed that all animals progressively learned
the task over time (Days) [F6 .5 ,509 .5 = 20.787,
p≤ 0.001]. Significant Days× Sex interactions were
also found [F6 .5 ,509 .5 = 2.334, p = 0.027], with sub-
sequent analysis showing that P301L-Tau females
are significantly slower in acquisition of the task
[F1 ,78 = 8.65, p = 0.004]. In addition, there were
significant Stress x Sex interactions [F1 ,78 = 11.03,
p < 0.001], attributable to the fact that only female mice
with the P301L-Tau genotype were responsive to the
deleterious effects of stress on this cognitive parame-
ter. The factors Age and Sex also displayed a significant
interaction [F1 ,78 = 3.989, p = 0.049] (cf. Fig. 1A, C).
Furthermore, the probe test revealed a Stress × Sex
interaction (F1 ,78 = 4.372, p = 0.04), and subsequent
analyses clearly demonstrated that stress has a sig-
nificant influence over the response of old female
(F1 ,44 = 7.08, p≤ 0.05), but not in male (F1 ,38 = 1.81,
p = 1.87), P301L-Tau animals (Fig. 1E, F). Stress did
not exert any influence over the behavior of wild-
type animals (data not shown). Overall, the above data
demonstrate that stress induces cognitive deficits in
female, but not male, P301L-Tau mice.
Stress aggravates the hippocampal burden of
P301L-Tau in a sex-speciﬁc manner
Previous studies showed that stress induces Tau
hyperphosphorylation and accumulation in neuronal
cultures [24] and brain areas, such as the hippocam-
pus, which are involved in the regulation of cognitive
processes [16, 17]. Since formation and aggregation
of insoluble Tau is the major pathological char-
acteristic triggered by the P301L-Tau mutation [3,
22], it was of interest to examine whether stress
alters Tau aggregation. To this end, we monitored
the levels of sarkosyl-insoluble Tau aggregates in
the hippocampi of P301L-Tau mice by western blot
analysis since these aggregates are biochemically
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Fig. 1. Stress-induced cognitive impairment in female but not male P301L-Tau animals. A–D) Spatial reference memory was tested using
the Morris water maze test for 9 consecutive days (3 trials per day) in middle-aged (A and B; 12–14 months old) and old (C and D; 22–24
months old) P301L-Tau Tg animals. Stress had a negative effect on the learning curve (represented by increased error score) of female (A,
C) but not male (B, D) P301L-Tau mice. E, F) A probe test at the end of the acquisition period showed that the cognition-impairing effects
of stress were more prominent in old versus middle-aged female mice; the error score in the probe test of stressed aged females was higher
than the control (non-stressed) aged females, an effect not seen in middle-aged animals (E). All numerical data shown represent mean ± SEM
(n = 10–12)∗(p < 0.05).
similar to those found in the neurofibrillary tan-
gles that characterize tauopathies, including AD. We
found that stress causes a significant increase in
the amount of sarkosyl-insoluble Tau in the hip-
pocampus of middle-aged and old female, but not
male, P301L-Tau mice, with a significant Stress x
Sex interaction [F1 ,16 (middle-aged ) = 6.314, p = 0.023;
F1 ,16 (Old ) = 5.635, p = 0.03] (Fig. 2A). In addi-
tion, post-hoc testing after Bonferroni’s correction
showed that no differences were present between
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Fig. 2. Stress increases levels of sarkosyl-insoluble Tau in the female, but not male, hippocampus. Representative immunoblots and quantification
of both sarkosyl-insoluble (A, B) and TBS-soluble (C, D) Tau levels in the hippocampus of male and female P301L-Tau Tg mice. Stress specifically
increased the levels of insoluble Tau (64 kDa Tau, detected by JM antibody) in the female hippocampus without exerting an effect on the male
hippocampus (A, B). In contrast, stress did not influence the levels of soluble Tau, detected by Tau5 antibody (C, D; h and m refer to human and
mouse Tau, respectively). All numerical data shown represent mean ± SEM values (n = 7–8), depicted with respect to data obtained in control
tissues (CON), set at 100% ∗(p < 0.05). E) Increased MC1 staining in stressed female hippocampus when compared to control females; this stress
effect was not obvious in males. Insets are high-power magnifications (20×) of the rectangular areas marked in the respective low-magnification
micrographs (4×).; bar 200m.
stressed and non-stressed males whereas stressed
and non-stressed females were significantly different
(pmiddle-aged = 0.008; pold = 0.007). The greater abun-
dance of insoluble Tau in the hippocampi of stressed
female P301L-Tau mice is in line with the greater
cognitive impairments found in these animals (cf.
Fig. 1A–D). Interestingly, hippocampal levels of total
soluble Tau were not influenced by stress in any
of the experimental groups (Fig. 2C, D). In addi-
tion, stress also did not alter the phosphorylation
pattern of soluble Tau, as assessed by a panel of dif-
ferent phospho-dependent antibodies (Supplementary
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Fig. 1). Together, our molecular analysis indicates that
stress specifically exerts its effect on insoluble Tau
species, without affecting soluble forms, suggesting
a detrimental effect of stress on Tau aggregation.
In a next step, we monitored levels of abnormally-
conformed Tau since abnormal Tau conformation is
an important step in Tau aggregation pathology [25].
Using the MC1 antibody which specifically stains
abnormally-folded Tau, an early pathogenic confor-
mation of Tau [26], we observed a greater number
of MC1-immunoreactive neurons in the hippocam-
pal CA3 subfield of female P301L-Tau mice that had
been exposed to the chronic stress protocol (Fig. 2C).
Furthermore, as P301L-Tau and its aggregates have
been shown to have neurotoxic properties [26] and
AD pathology in humans is characterized by reduc-
tion in neuronal number, we estimated hippocampal
cell number using stereological tools. We found that
stress resulted in a significant reduction of CA3 cell
density in old P301L-Tau females (CON 7.539 ± 0.15
and STR 6.796 ± 0.13; p < 0.05) without affecting
neuronal numbers in male P301L-Tau mice (CON
7.562 ± 0.16 and STR 7.711 ± 0.27). The greater
severity of cognitive deficits observed in old stressed
P301L-Tau females (compared to middle-agedP301L-
Tau females) (Fig. 1A) suggests that mechanisms
other than cell loss alone contribute to stress-triggered
impairments of memory during the early stages of Tau
aggregation.
Stress-triggered degenerative mechanisms in the
hippocampus of female P301L-Tau transgenic
mice
We previously observed that exposure of neural
cells to glucocorticoids, the main stress hormones,
decreases Tau turnover resulting in its cytoplasmic
accumulation [24]. Interestingly, glucocorticoid recep-
tors partner with various molecular chaperones and
co-chaperones [27], also implicated in the clearance
of misfolded proteins, including Tau [18, 19]. Thus,
it was of interest to monitor stress-induced changes
in the levels of some molecular chaperones that are
critically involved in protein clearance and/or aggre-
gation. Using a panel of antibodies against relevant
molecular chaperones, we here observed that stress in
female P301L-Tau mice leads to significant decreases
in hippocampal levels of Hsp70, and its co-chaperone
Hsp105 (p < 0.05; Fig. 3A, B), both of which are sug-
gested to play an essential role in the degradation
of misfolded Tau [18]. In contrast, stress resulted in
increased levels of Hsp90 (Fig. 3A, B); this chaper-
one was previously shown to increase the stability of
P301L-Tau and its aggregates [28, 29]; levels of other
chaperones examined (Hsp60, Hsp27, and 40) were
not altered by stress (Fig. 3A, B). These changes were
not observed in the hippocampus of stressed males
(Fig. 3E, F).
While many studies suggest activation of the apop-
totic machinery in AD brains, it is presently debated
whether the finding of apoptosis-related markers in the
postmortem brains of AD patients [30] reflects neu-
ronal loss through apoptotic mechanisms ([31, 32].
We found that exposure to stress evoked a signifi-
cant increase in the protein levels of the pro-apoptotic
molecule Bax with small decreases in Bcl-xL and Bcl-
2 levels in the female hippocampus (Fig. 3A, C), the net
result of which was an increase in the pro-apoptotic:
anti-apoptotic protein ratio (p≤ 0.05; Fig. 3D); note
that this effect of stress was not found in the male
P301L-Tau hippocampus (Fig. 3E, G, H) Consistent
with the findings of Spines-Jones et al. [31] and de
Calignon et al. [32], we failed to observe marked his-
tochemical signs of apoptosis in the hippocampi of
stressed P301L mice. However, stress led to a sig-
nificant increase in the levels of C-terminal caspase
3-cleaved Tau (Tau truncated at D421, also referred
Tau-C3) when P301L female mice were exposed to
stress (Fig. 3C); again, stress did not increase trun-
cated Tau levels in the male P301L-Tau hippocampus
(Fig. 3G). Since Tau-C3 is more prone to fibrilliza-
tion and aggregation [25, 32], it is highly plausible
that stress-driven increases in Tau-C3 also significantly
contribute to the increases of Tau aggregates in the
hippocampi of stressed female P301L-Tau mice.
DISCUSSION
Despite considerable progress in the understanding
of the pathophysiology and neurobiology of neu-
rodegenerative disorders, AD remains a complex,
multifactorial disorder with many risk factors that
include age, sex, and stressful life events [5, 13,
14], whose effects occur through largely undefined
mechanisms. While both AD and the endocrine and
behavioral response to stress display clear sex-specific
profiles (females appear more vulnerable) [6, 8, 10],
there is a paucity of research aimed to explain these
differences (National Institute of Mental Health 2011).
The present study considered clinically relevant risk
factors of AD pathology, namely aging, sex, and stress
on the progression of Tau pathology.
The present results demonstrate that exposure to
chronic stress aggravates Tau pathology by increasing
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Fig. 3. Stress-induced changes in molecular chaperones and apoptotic markers in the hippocampus of female P301L-Tau mice. Representative
blots and quantitative analysis showing the effects of stress on the hippocampus of female (A–D) and male (E–H) P301L-Tau mice. Stress
reduced the protein levels of the molecular chaperones Hsp70 and Hsp105 and (B) increased those of Hsp90 in female P301L-Tau animals;
stress did not exert any effect on the expression of these proteins in P301L-Tau males (F). In addition, stress activated the biochemical machinery
associated with apoptosis in female hippocampus (C), significantly increasing Bax and reducing Bcl-2 and Bcl-xL protein levels, thus favoring
an increase in the Bax/Bcl-2 ratio (D); similar changes were not observed in the male hippocampus (G, H). Truncated Tau levels (detected by
TauC3 antibody) were increased by stress in the hippocampus of female (C), but not male (G), P301L-Tau Tg animals. All numerical data shown
represent mean ± SEM values (n = 6–7), depicted with respect to data obtained in control tissues (CON), set at 100% (*p < 0.05).
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the aggregation of sarkosyl-insoluble Tau, C-terminal
truncation of Tau by caspase-3 and, abnormal con-
formation of Tau in the hippocampus of female
P301L-Tau mice. Indeed, both truncation and abnor-
mal conformation of Tau precede its aggregation and
formation of neurofibrillary tangles [25, 26, 32], thus
serving as early markers of disease. It is suggested that
the Tau-C3 species contributes to misfolding of Tau
into a conformation that can nucleate and recruit other
Tau molecules into aggregates [25, 32, 33]. Consistent
with a previous suggestion that Tau aggregation does
not depend on Tau phosphorylation [33], we observed
that stress-triggered Tau aggregation is not accompa-
nied by increased Tau hyperphosphorylation. We also
found that stress impairs cognition in the absence of
neurofibrillary tangles, a finding in line with the obser-
vation of initial deposition of mutant P301L-Tau in
pre-tangle aggregates of human subjects expressing the
P301L-Tau mutation [34].
Disturbances in the degradation of misfolded Tau
protein are suggested to underlie the aggregation of Tau
[18]. Tau degradation critically depends on the bind-
ing of Tau to molecular chaperones which target the
protein for degradation [18, 35, 36]. The present study
showed that stress downregulates hippocampal levels
of Hsp70 and its co-chaperone, Hsp105. This find-
ing is consistent with the reported inverse correlation
between increased insoluble Tau and decreased Hsp70
protein in the postmortem brains from AD patients [37]
as well as in vitro observations that Hsp70 promotes
the degradation of insoluble, but not soluble, Tau [18].
Further, we found that stress leads to an increase in hip-
pocampal levels of Hsp90. This chaperone is known to
stabilize both mutant P301L-Tau protein [29] and its
aggregates [28]. Pharmacological inhibition of Hsp90
was previously, shown to upregulate Hsp70 levels [35]
and to reduce the levels of insoluble Tau [22]; thus, the
dynamic cycling of the two chaperones with opposing
actions may play an important role in the clearance
of misfolded proteins; whereas Hsp70 promotes sub-
strate ubiquitination, Hsp90 inhibits ubiquitination
[38]. Interestingly, Hsp90 and Hsp70 serve to main-
tain the glucocorticoid receptor (GR) in a high affinity
state; upon binding of ligand (glucocorticoid) to the
GR, these heat shock proteins dissociate from the Hsp-
GR complex, facilitating nuclear import of liganded
GR where it initiates transcription; Hsp90 has also
been implicated in GR recycling [39, 40]. The stress-
induced increases in Hsp90 observed here indicate
that GR are constantly available for binding ligand,
thus adding impetus to the vicious cycle initiated by
stress.
We previously showed that glucocorticoids stimu-
late apoptosis in the hippocampus. Here, we report
that hippocampi of stressed P301L-Tau mice displayed
increases in the ratio of pro-apoptotic (Bax) versus
anti-apoptotic (Bcl-2 and BClXL) protein expression
with concomitant increases in caspase-dependent trun-
cated Tau (Tau-C3), but without any overt signs of
ongoing apoptosis. While many studies support the
involvement of Tau aggregates in neuronal injury and
degeneration [3, 4] and AD brains exhibit markers of
caspase activation and apoptosis (e.g., active caspase-3
and Bax), the role of apoptosis in AD remains contro-
versial [32] as apoptosis does not seem to be a major
contributor to neuronal death in human tauopathies
[41] and Tg mouse models [42], although it should also
be noted that apoptotic cells are rapidly cleared, mak-
ing their detection in chronic stress difficult. Recent
evidence suggests other functions (e.g., regulation of
synaptic function and plasticity) for proteins, other-
wise, best known for their role in apoptosis [43, 44];
further, caspase-cleaved Tau is suggested to contribute
to synaptic deficits [44, 45], compromised mitochon-
drial function [46], and cellular demise [25]. Given
that Tau-accumulating neurons survive for many years
[47], it has been suggested that active-caspase-3 and
other apoptosis-related enzymes may contribute to dis-
ease progression without necessarily triggering acute
neuronal death [31, 32, 46]. Indeed, Rohn et al. [48]
demonstrated that expression of the anti-apoptotic
Bcl-2 protein in 3xTg-AD mice reduced caspase acti-
vation, Tau truncation, and tangle formation, providing
an additional causal role for the above molecules
in the pathological mechanisms involved in Tau
aggregation.
The Tau pathology observed in the hippocampus of
female P301L-Tau mice that had been exposed to stress
translated into deficits in spatial reference memory, a
hippocampal dependent task. This effect was accentu-
ated by age; detailed statistical analyses on the present
data point to complex interactions between genotype,
stress, and sex, all of which have been previously iden-
tified as individual factors contributing to AD [7, 11,
12]. Notably, the lack of Tau aggregation-associated
cognitive impairment in non-Tg animals highlights
these interactions and their convergence to amplify
the phenotype of P301L-Tau mice. In addition, future
studies are needed to clarify the interaction between
stress and glutamate release on the development and
spread of Tau pathology since i) glutamate-dependent
extracellular Tau seems to be involved in disease propa-
gation [49] and, ii) glutamate plays an important role in
mediating the cellular and electrophysiological actions
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of glucocorticoids [50, 51] that are released during
stress.
Insight into the neurobiological basis of sex dif-
ferences in susceptibility to develop AD in humans
is difficult to obtain. However, a recent report that
showed that stress induces the overproduction of
amyloid-, another key player in AD pathology, in
the hippocampus of female (but not of male) 5xTg
mice [52] supports our findings with respect to the
increased vulnerability of the female hippocampus to
stress-triggered Tau pathology. Age-related decrease
in neuroprotective estrogen and progesterone (and its
derivatives) is a plausible explanation for the propen-
sity of post-menopausal women to develop AD [11,
53, 54]. Comparisons between the human female and
mouse reproductive cycles are not justified for many
reasons (see [55]). This study did not specifically
investigate the role of reproductive aging in stress-
triggered pathology. Nevertheless, it should be noted
that sex steroids are notoriously difficult to mea-
sure using standard methods in female rodents [56],
although there are reports that aged female rodents
may secrete low levels of estrogen even after the loss
of regular ovarian cyclicity after about 1 year of age
([57, 58] and reviewed in [55]). Our results show
that, contrary to males, both middle-age (12 months
old), and old (22 month old) stressed females dis-
played similar behavioral and biochemical patterns,
suggesting that age-related reproductive senescence
is unlikely to be the main underlying factor for the
herein-observed sex-related differences in the response
of P301L-Tau mice to stress; on the other hand, even
slight age-related reductions in sex hormone levels
could potentially exacerbate the effects of stress in the
old versus middle-aged female animals (see Fig. 1).
Nevertheless, it would be important to know whether
sex per se determines a given pathological trajectory;
for example, future studies could examine whether the
herein observed sex differences arise from the organiz-
ing actions of sex steroids during early development
and/or are dependent on the activating actions of sex
steroids for their manifestation over the reproductive
life cycle [8, 10, 59]. Interestingly, a recent study
showed that de-masculinization of neonatal male 3xTg
mice narrows the gender gap in terms of amyloid-
pathology [60].
In summary, the current study provides new infor-
mation on the cellular mechanisms through which
chronic stress may precipitate Tau aggregation pathol-
ogy and cognitive impairment (see Fig. 4). In light of
current AD clinical trials aiming to block Tau aggre-
gation, this study adds to our knowledge of disease
Fig. 4. The role of chronic stress on cellular pathways that result
in Tau aggregation pathology. This working model summarizes how
stress might trigger different parts of the Tau aggregation machinery.
Exposure to chronic stress triggers caspase 3-mediated Tau trunca-
tion and abnormal conformation; two cellular phenomena suggested
to be involved in Tau oligomerization and ultimately, aggregation,
that eventually result in neuronal loss and cognitive impairments
[3, 20, 25, 31, 32]. In parallel, stress dysregulates the molecular
chaperone machinery by increasing Hsp90 and decreasing Hsp70
levels, thus reducing Tau degradation. Note that Hsp90 is a suggested
therapeutic target as its inhibition upregulates Hsp70 and reduces
insoluble Tau [22, 33]. In addition, stress activates the apoptotic
machinery which may contribute to Tau truncation and aggregation
[46], as well as synaptic deficits [38, 43], compromised mitochon-
drial function and cell death [25, 44].
etiopathogenesis and highlights the important interplay
between stress and other clinically-relevant precipitat-
ing factors for Tau pathology development supporting
the emerging idea that the female hippocampus is
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inherently more vulnerable to stress-related disorders
of the brain.
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